Chi Zhang

Chi Zhang

Auto-generated profile, based on publicly available information

Chi Zhang

Department of Orthopaedics, North District, the First Affiliated Hospital of Anhui Medical University, Hefei, 230000, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2016 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
AKA. L. Kepley
A. L. Kepley
KNK. K. Nishiyama
K. K. Nishiyama
BZB. Zhou
B. Zhou
JWJ. Wang
J. Wang
CZC. Zhang
C. Zhang
TNT. L. Nickolas
T. L. Nickolas

3 November 2023 in Asian Journal of Surgery
Verified
Journal Article
Open access
CZChi Zhang
Chi Zhang
JCJun Chang
Jun Chang
GMGuangWen Ma
GuangWen Ma

4 January 2024 in Asian Journal of Surgery
Verified
Journal Article
Open access
CZChi Zhang
Chi Zhang
JCJun Chang
Jun Chang
YWYunFeng Wu
YunFeng Wu
GMGuangWen Ma
GuangWen Ma

24 August 2026 in Journal of Translational Internal Medicine
Verified
Journal Article
Open access
HWHao Wang
Hao Wang
RYRui Yang
Rui Yang
ZWZhongxuan Wu
Zhongxuan Wu
MZMian Zhang
Mian Zhang
LXLongze Xiao
Longze Xiao
YHYong Hu
Yong Hu
Background and Objectives: Osteosarcoma (OS) is an aggressive bone cancer with a poor prognosis, especially in metastatic cases. The tumor microenvironment (TME), particularly tumor-associated macrophages (TAMs), plays a crucial role in its progression. This study aimed to investigate the role and mechanism of the tripartite motif-containing 65 (TRIM65), B-cell translocation gene 3 (BTG3), hypoxia-inducible factor 1α (HIF-1α; TRIM65-BTG3-HIF-1α) signaling axis in regulating TAMs and angiogenesis in OS. Methods: Bioinformatic analysis of The Cancer Genome Atlas (TCGA) and TARGET-OS datasets identified M2 macrophage-related genes. Clinical OS samples were analyzed via immunohistochemistry (IHC), immunofluorescence (IF), messenger ribonucleic acid (mRNA) sequencing, and data-independent acquisition (DIA) quantitative proteomics. In vitro functional assays (cell counting kit-8 [CCK-8], colony formation, transwell migration/invasion, tube formation) and in vivo subcutaneous xenograft models in nude mice were performed using OS cell lines (U-2 OS [U2OS], sarcoma osteogenics [SAOS], human OS (HOS), 143B) and the human fetal osteoblast (hFOB) normal osteoblast line. Macrophage polarization was induced from Tohoku Hospital pediatrics-1 (THP-1) cells. Molecular interactions were assessed by co-immunoprecipitation (Co-IP), ubiquitination assays, and luciferase reporter assays. Results: High infiltration of M2 macrophages correlated with poor patient prognosis. BTG3 was identified as a key M2-related gene exhibiting a "transcriptional upregulation with translational downregulation" pattern in OS. TRIM65, an E3 ubiquitin ligase upregulated in OS, directly interacted with and promoted the ubiquitin-mediated degradation of the BTG3 protein. Knockdown of TRIM65 inhibited OS cell proliferation, migration, invasion in vitro , and tumor growth in vivo . BTG3 acted as a negative regulator of HIF-1α transcriptional activity. Loss of BTG3 led to HIF-1α activation, which in turn promoted M2 polarization and enhanced migration of macrophages. Furthermore, conditioned medium from BTG3-deficient cells significantly promoted endothelial cell migration and tube formation, indicating enhanced angiogenesis. This pro-angiogenic effect was dependent on HIF-1α activation. Conclusions: We delineate a novel TRIM65-BTG3-HIF-1α signaling axis in OS. TRIM65 degrades BTG3, leading to HIF-1α activation, which drives M2 macrophage polarization and angiogenesis, ultimately fostering tumor progression. Targeting this axis may offer a promising therapeutic strategy for OS.

5 January 2024 in Asian Journal of Surgery
Verified
Journal Article
Open access
CZChi Zhang
Chi Zhang
LLLiyin Liu
Liyin Liu
TCTao Chen
Tao Chen